Jarosław Kępski/LinkedIn
Dec 13, 2025, 08:22
Jarosław Kępski: Managing Anticoagulation in Oncology Patients With Thrombocytopenia
Jarosław Kępski, Cardiologist and member of the ESC Council of Cardio-Oncology (COOL) Committee, reposted from Davood KHoda-Amorzideh on LinkedIn:
”Thrombocytopenia presents a particular challenge in oncology, especially when patients require anticoagulation. We invite you to read our analysis of current recommendations.”
Quoting Davood KHoda-Amorzideh‘s post:
”Anticoagulant – therapy in patients with cancer and thrombocytopenia.”
Title: Anticoagulant therapy in patients with cancer and thrombocytopenia
Author: Sebastian Szmit, Jarosław Kępski, Ewa Lech-Marańda, Dariusz M. Kowalski, Maciej Krzakowski, Magdalena Zaborowska-Szmit
Read the full article here.
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke